Prevention of Type 2 Diabetes After Gestational Diabetes A Randomized Controlled Study Using Digital and Personal Support for Women in Primary Care

What this Trial Is About

Gestational diabetes mellitus GDM is a common metabolic problem during pregnancy, affecting 2-10% of pregnant women in Sweden depending on screening methods. Women with GDM face about a 50% chance of developing type 2 diabetes T2DM within 20 years. This research evaluates a lifestyle intervention model using both personal and technical support to help prevent T2DM after pregnancy, aiming for an inexpensive and easy-to-implement approach within regular primary care. Participants will be randomly assigned to receive either the lifestyle intervention or usual care. The intervention includes support at every visit to the Child Health Care Centre with blood tests, measurements, and guidance on diet and physical activity. Participants also get access to a digital platform called MyMOWO, which offers personalized exercise programs and health coaching. Women in the usual care group continue with standard follow-up at health care units. A control group of women with normal glucose tolerance will also be studied. Throughout the study, women will have physical examinations, blood tests including oral glucose tolerance tests, questionnaires on lifestyle and diet, and fitness tests like VO2max. Measurements will take place at baseline, one year, 18 months, four years, and five years after delivery. Data on insulin resistance, blood sugar control, fitness, wellbeing, and glucose tolerance will be collected. Women who become pregnant again during the study will be excluded from final analysis but encouraged to stay involved. The total participation duration is up to five years, with ongoing monitoring and support.

Gestational Diabetes - PrEvention of PostPartum Diabetes Study